IL-37 also directly inhibits tumor cell invasion and migration by suppressing the IL-6/STAT3 signaling pathway and its downstream targets, including Bcl-2, NEDD9, and cyclin D1 (137). This evidence concerns the gene IL37 and neoplasm.